Interactions of flavonoids with biomacromolecules

Current Organic Chemistry

Volumn 15, Issue 15, 2011, Pages 2627-2640

  Ma, Ji ^a   Yin, Yu Min ^a   Liu, Hai Ling ^a   Xie, Meng Xia ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Binding mode; Flavonoids; Flavonol; Fluorescence enhancement; Nucleic acids; Protein; Spectroscopic methods

Indexed keywords

BINDING ENERGY; BINDING SITES; BIOMOLECULES; DICHROISM; FLAVONOIDS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PROTEINS; SPECTROSCOPIC ANALYSIS;

BINDING MODES; BINDING-SITES; BIOMACROMOLECULE; BROAD SPECTRUM; FLAVONOID; FLAVONOL; FLUORESCENCE ENHANCEMENT; PHARMACOLOGICAL ACTIVITY; PLANT KINGDOM; SPECTROSCOPIC METHOD;

NUCLEIC ACIDS;

EID: 79960022318     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527211796367345     Document Type: Article

References (230)

1. Teillet, F.; Boumendjel, A.; Boutonnat, J.; Ronot, X. Flavonoids as RTKinhibitors and potential anticancer agents. Med. Res. Rev., 2008, 28, 715-745.
2. Middleton, E. Effect of Plant Flavonoids on Immune and Inflammatory Cell Function; Manthey, J. A.; Buslig, B. S., Eds. Flavonoids in the Living System: New York, 1998; Vol. 439, pp 175-182.
3. de Groot, H.; Rauen, U. Tissue injury by reactive oxygen species and theprotective effects of flavonoids. Fundam. Clin. Pharmacol., 1998, 12, 249-255.
4. Hertog, M. G. L.; Feskens, E. J. M.; Hollman, P. C. H.; Katan, M. B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease:the Zutphen elderly study. Lancet, 1993, 342, 1007-1011.
5. Blot, W. J.; McLaughlin, J. K.; Chow, W. H. Cancer rates among drinkers of black tea. Crit. Re. Food Sci. Nutr., 1997, 37, 739-760.
6. Duthie, G. G.; Duthie, S. J.; Kyle, J. A. M. Plant polyphenols in cancer andheart disease: implications as nutritional antioxidants. Nutr. Res. Rev., 2000,13, 79-106.
7. Brenna, O. V.; Pagliarini, E. Multivariate analysis of antioxidant power andpolyphenolic composition in red wines. J. Agric. Food Chem., 2001, 49,4841-4844.
8. Counet, C.; Collin, S. Effect of number of flavanol units on the antioxidantactivity of procyanidin fractions isolated from chocolate. J. Agric. Food Chem., 2003, 51, 6816-6822.
9. Rice-Evans, C.; Miller, N. J.; Paganga, G. Structure-antioxidant activityrelationships of flavonoids and phenolic acids. Free Radical Biol. Med.,1996, 20, 933-956.
10. Brahmachari, G.; Gorai, D. Progress in the research on naturally occurringflavones and flavonols: an overview. Curr. Org. Chem., 2006, 10, 873-898.
11. Ross, J. A.; Kasum, C. M. Dietary flavonoids: bioavailability, metaboliceffects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34.
12. Balaban, R. S.; Nemoto, S.; Finkel, T. Mitochondria, oxidants, and aging. Cell, 2005, 120, 483-495.
13. Noda, Y.; Kaneyuki, T.; Mori, A.; Packer, L. Antioxidant activities of pomegranatefruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J. Agric. Food. Chem., 2002, 50, 166-171.
14. Seeram, N. P.; Adams, L. S.; Hardy, M. L.; Heber, D. Total cranberry extractversus its phytochemical constituents: antiproliferative and synergistic effectsagainst human tumor cell lines. J. Agric. Food. Chem., 2004, 52, 2512-2517.
15. Silva, M. M.; Santos, M. R.; Caroco, G.; Rocha, R.; Justino, G.; Mira, L. Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radical Res., 2002, 36, 1219-1227.
16. Yu, J.; Wang, L. M.; Walzem, R. L.; Miller, E. G.; Pike, L. M.; Patil, B. S. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J. Agric.Food. Chem., 2005, 53, 2009-2014.
17. Teixeira, S.; Siquet, C.; Alves, C.; Boal, I.; Marques, M. P.; Borges, F.; Lima, J.; Reis, S. Structure-property studies on the antioxidant activity offlavonoids present in diet. Free Radical Biol. Med., 2005, 39, 1099-1108.
18. Kris-Etherton, P. M.; Lefevre, M.; Beecher, G. R.; Gross, M. D.; Keen, C.L.; Etherton, T. D. Bioactive compounds in nutrition and health-researchmethodologies for establishing biological function: the antioxidant and antiinflammatoryeffects of flavonoids on atherosclerosis. Annu. Rev. Nutr.,2004, 24, 511-538.
19. Pietta, P. G. Flavonoids as antioxidants. J. Nat. Prod., 2000, 63, 1035-1042.
20. Dangles, O.; Dufour, C.; Manach, C.; Mornad, C.; Remesy, C. Binding offlavonoids to plasma proteins. Methods Enzymol., 2001, 335, 319-334.
21. Yang, C. S.; Landau, J. M.; Huang, M. T.; Newmark, H. L. Inhibition ofcarcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr., 2001,21, 381-406.
22. Adhami, V. M.; Mukhtar, H. Polyphenols from green tea and pomegranatefor prevention of prostate cancer. Free Radical Res., 2006, 40, 1095-1104
23. Ren, W. Y.; Qiao, Z. H.; Wang, H. W.; Zhu, L.; Zhang, L. Flavonoids:promising anticancer agents. Med. Res. Rev., 2003, 23, 519-534.
24. Harborne, J. B.; Williams, C. A. Advances in flavonoid research since 1992.Phytochemistry, 2000, 55, 481-504.
25. Erlund, I. Review of the flavonoids quercetin, hesperetin naringenin. Dietarysources, bioactivities, and epidemiology. Nutr. Res., 2004, 24, 851-874.
26. Moon, Y. J.; Wang, X. D.; Morris, M. E. Dietary flavonoids: effects onxenobiotic and carcinogen metabolism. Toxicol. in Vitro, 2006, 20, 187-210.
27. Liu, H. L.; Jiang, W. B.; Xie, M. X. Flavonoids: recent advances as anticancerdrugs. Recent Pat Anticancer Drug Discov, 2010, 5, 152-164.
28. Kale, A.; Gawande, S.; Kotwal, S. Cancer phytotherapeutics: role for flavonoidsat the cellular level. Phytother. Res., 2008, 22, 567-577.
29. Birt, D. F.; Hendrich, S.; Wang, W. Q. Dietary agents in cancer prevention:flavonoids and isoflavonoids. Pharm.Therap., 2001, 90, 157-177.
30. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related tocancer chemoprevention. J. Nutr. Biochem., 2007, 18, 427-442.
31. Pan, M. H.; Ho, C. T. Chemopreventive effects of natural dietary compoundson cancer development. Chem. Soc. Rev., 2008, 37, 2558-2574.
32. Dixon, R. A.; Ferreira, D. Genistein. Phytochemistry, 2002, 60, 205-211.
33. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention byquercetin. Cancer Lett., 2008, 269, 315-325.
34. Walle, T. Methoxylated flavones, a superior cancer chemopreventive flavonoidsubclass? Semin. Cancer Biol., 2007, 17, 354-362.
35. Aron, P. M.; Kennedy, J. A. Flavan-3-ols: nature, occurrence and biologicalactivity. Mol. Nutr. Food Res., 2008, 52, 79-104.
36. Nandakumar, V.; Singh, T.; Katiyar, S. K. Multi-targeted prevention andtherapy of cancer by proanthocyanidins. Cancer Lett., 2008, 269, 378-387.
37. Wang, L. S.; Stoner, G. D. Anthocyanins and their role in cancer prevention. Cancer Lett., 2008, 269, 281-290.
38. Spencer, J. P. E. The impact of flavonoids on memory: physiological andmolecular considerations. Chem. Soc. Rev., 2009, 38, 1152-1161.
39. Kashiwada, Y.; Aoshima, A.; Ikeshiro, Y.; Chen, Y. P.; Furukawa, H.; Itoigawa, M.; Fujioka, T.; Mihashi, K.; Cosentino, L. M.; Morris-Natschke, S.L.; Lee, K. H. Anti-HIV benzylisoquinoline alkaloids and flavonoids fromthe leaves of Nelumbo nucifera, and structure-activity correlations with relatedalkaloids. Bioorg. Med. Chem., 2005, 13, 443-448.
40. Hu, C. Q.; Chen, K.; Shi, Q.; Kilkuskie, R. E.; Cheng, Y. C.; Lee, K. H. Anti-AIDS agents 10. acacetin-7-o-beta-D-galactopyranoside, an anti-HIVprinciple from chrysanthemum-morifolium and a structure-activity correlationwith some related flavonoids. J. Nat. Prod., 1994, 57, 42-51.
41. Olivero-Verbel, J. D.; Pacheco-Londono, L. Structure-activity relationshipsfor the anti-HIV activity of flavonoids. J. Chem. Inf. Comput. Sci., 2002, 42,1241-1246.
42. Havsteen, B. H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 2002, 96, 67-202.
43. Friedman, M. Overview of antibacterial, antitoxin, antiviral, and antifungalactivities of tea flavonoids and teas. Mol. Nutr. Food Res., 2007, 51, 116-134.
44. Stan, D.; Matei, I.; Mihailescu, C.; Savin, M.; Matache, M.; Hillebrand, M.; Baciu, I. Spectroscopic investigations of the binding interaction of a new indanedionederivative with human and bovine serum albumins. Molecules,2009, 14, 1614-1626.
45. Rasoulzadeh, F.; Jabary, H. N.; Naseri, A.; Rashidi, M. R. Fluorescencequenching study of quercetin interaction with bovine milk xanthine oxidase. Spectrochim. Acta, Part A, 2009, 72, 190-193.
46. Ragazzon, P. A.; Bradshaw, T.; Matthews, C.; Iley, J.; Missailidis, S. Thecharacterisation of flavone-DNA isoform interactions as a basis for anticancerdrug development. Anticancer Res., 2009, 29, 2273-2283.
47. Mandeville, J. S.; Froehlich, E.; Tajmir-Riahi, H. A. Study of curcumin andgenistein interactions with human serum albumin. J. Pharm. Biomed. Anal.,2009, 49, 468-474.
48. Yang, Y. M.; Hu, Q. L.; Fan, Y. L.; Shen, H. S. Study on the binding ofluteolin to bovine serum albumin. Spectrochim. Acta, Part A, 2008, 69, 432-436.
49. Xiao, J.; Chen, X.; Zhang, L.; Talbot, S. G.; Li, G. C.; Xu, M. Investigationof the mechanism of enhanced effect of EGCG on huperzine A's inhibition ofacetylcholinesterase activity in rats by a multispectroscopic method. J. Agric.Food. Chem., 2008, 56, 910-915.
50. Qi, Z.; Zhang, Y.; Liao, F. L.; Ou-Yang, Y. W.; Liu, Y.; Yang, X. Probingthe binding of morin to human serum albumin by optical spectroscopy. J. Pharm. Biomed. Anal., 2008, 46, 699-706.
51. Hui, C.; Quan, L.; Jian, S.; Jian, B. X.; Ming, X. Comparing the affinities offlavonoid isomers with protein by fluorescence spectroscopy. Anal. Lett.,2008, 41, 521-532.
52. Gentili, P. L.; Ortica, F.; Favaro, G. Static and dynamic interaction of anaturally occurring photochromic molecule with bovine serum albumin studiedby UV-visible absorption and fluorescence spectroscopy. J. Phys. Chem.B, 2008, 112, 16793-16801.
53. Banerjee, A.; Basu, K.; Sengupta, P. K. Interaction of 7-hydroxyflavone withhuman serum albumin: a spectroscopic study. J. Photochem. Photobiol. B:Biol., 2008, 90, 33-40.
54. Zhou, N.; Liang, Y. Z.; Wang, P. 18 beta-Glycyrrhetinic acid interaction withbovine serum albumin. J. Photochem. Photobiol. A: Chem., 2007, 185, 271-276.
55. Yuan, J. L.; Lv, Z.; Liu, Z. G.; Hu, Z.; Zou, G. L. Study on interaction betweenapigenin and human serum albumin by spectroscopy and molecularmodeling. J. Photochem. Photobiol. A: Chem., 2007, 191, 104-113.
56. Tang, J. H.; Lian, N.; Bi, C. L.; Li, W. H. Analysis of eupatilin-human serumalbumin interactions by means of spectroscopic and computational modelling. J. Pharm. Pharmacol., 2007, 59, 637-643.
57. Soares, S.; Mateus, N.; De Freitas, V. Interaction of different polyphenolswith bovine serum albumin (BSA) and human salivary alpha-amylase (HSA)by fluorescence quenching. J. Agric. Food Chem., 2007, 55, 6726-6735.
58. Qin, C.; Xie, M. X.; Liu, Y. Characterization of the myricetin-human serumalbumin complex by spectroscopic and molecular modeling approaches. Biomacromolecules,2007, 8, 2182-2189.
59. Pastukhov, A. V.; Levchenko, L. A.; Sadkov, A. P. Spectroscopic study onbinding of rutin to human serum albumin. J. Mol. Struct., 2007, 842, 60-66.
60. Bohl, M.; Tietze, S.; Sokoll, A.; Madathil, S.; Pfennig, F.; Apostolakis, J.; Fahmy, K.; Gutzeit, H. O. Flavonoids affect actin functions in cytoplasm andnucleus. Biophys. J., 2007, 93, 2767-2780.
61. Wang, F.; Yang, J. H.; Wu, X.; Wang, X. B.; Sun, C. X.; Liu, S. F.; Guo, C.Y. Molecular self-assembling and the fluorescence enhancement in morin-Al3+-cetyltrimethylammonium bromide-protein system. Biochimie, 2006, 88,121-129.
62. Mahesha, H. G.; Singh, S. A.; Srinivasan, N.; Rao, A. G. A. A spectroscopicstudy of the interaction of isoflavones with human serum albumin. Febs J.,2006, 273, 451-467.
63. Li, Y.; Yao, X.; Jin, J.; Chen, X.; Hu, Z. Interaction of rhein with humanserum albumin investigation by optic spectroscopic technique and modelingstudies. Biochim. Biophys. Acta, 2007, 1774, 51-58.
64. Pascal, C.; Poncet-Legrand, C.; Imberty, A.; Gautier, C.; Sarni-Manchado, P.; Cheynier, V.; Vernhet, A. Interactions between a non glycosylated humanproline-rich protein and flavan-3-ols are affected by protein concentrationand polyphenol/protein ratio. J. Agric. Food. Chem., 2007, 55, 4895-4901.
65. Martini, S.; Bonechi, C.; Rossi, C. Interaction of quercetin and its conjugatequercetin 3-O-ss-D-glucopyranoside with albumin as determined by NMRrelaxation data. J. Nat. Prod., 2008, 71, 175-178.
66. Richard, T.; Lefeuvre, D.; Descendit, A.; Quideau, S.; Monti, J. P. Recognitioncharacters in peptide-polyphenol complex formation. Biochim. Biophys.Acta, 2006, 1760, 951-958.
67. Liu, J.; Wang, X. R.; Cai, Z. W.; Lee, F. S. C. Effect of tanshinone IIA onthe noncovalent interaction between warfarin and human serum albuminstudied by electrospray ionization mass spectrometry. J. Am. Soc. Mass.Spectrom., 2008, 19, 1568-1575.
68. Lu, Q. H.; Ba, C. D.; Chen, D. Y. Investigating noncovalent interactions ofrutin - serum albumin by capillary electrophoresis - frontal analysis. J. Pharm. Biomed. Anal., 2008, 47, 888-891.
69. Diniz, A.; Escuder-Gilabert, L.; Lopes, N. P.; Villanueva-Camanas, R. M.; Sagrado, S.; Medina-Hernandez, M. J. Characterization of interactions betweenpolyphenolic compounds and human serum proteins by capillary electrophoresis. Anal. Bioanal.Chem., 2008, 391, 625-632.
70. Shailza, S.; Sharma, D. K.; Malik, B. K. Molecular modeling and dockingstudies of protein kinase C in prostate cancer for rational drug-design. Res. J.Biotechnol., 2007, 2, 7-19.
71. Lin, L.; Wei, D. Q.; Wang, J. F.; Chou, K. C. Computational studies of thebinding mechanism of calmodulin with chrysin. Biochem. Biophys. Res.Commun., 2007, 358, 1102-1107.
72. Chen, G. F.; Ma, X.; Meng, F. B.; Li, G. X. The electron transfer reactivityof kaempferol and its interaction with amino acid residues. Bioelectrochemistry,2008, 72, 169-173.
73. Lotito, S. B.; Frei, B. Dietary flavonoids attenuate tumor necrosis factoralpha-induced adhesion molecule expression in human aortic endothelialcells - structure-function relationships and activity after first pass metabolism.J. Biol. Chem., 2006, 281, 37102-37110.
74. Kim, S.; Kim, S. H.; Hur, S. M.; Lee, S. K.; Kim, W. W.; Kim, J. S.; Kim, J.H.; Choe, J. H.; Nam, S. J.; Lee, J. E.; Yang, J. H. Silibinin prevents TPAinducedMMP-9 expression by down-regulation of COX-2 in human breastcancer cells. J. Ethnopharmacol., 2009, 126, 252-257.
75. 2+/ROS/MAPK-dependentmechanism in vitro and glioma tumor growth in vivo. Neurochem. Res.,2009, 34, 1479-1490.
76. Dhanalakshmi, S.; Agarwal, C.; Singh, R. P.; Agarwal, R. Silibinin upregulatesDNA-protein kinase-dependent p53 activation to enhance UVBinducedapoptosis in mouse epithelial JB6 cells. J. Biol. Chem., 2005, 280,20375-20383.
77. Lu, H.; Chang, D. J.; Baratte, B.; Meijer, L.; Schulze-Gahmen, U. Crystalstructure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. J. Med. Chem., 2005, 48, 737-743.
78. Tang, G.; Ding, K.; Nikolovska-Coleska, Z.; Yang, C.-Y.; Qiu, S.; Shangary, S.; Wang, R.; Guo, J.; Gao, W.; Meagher, J.; Stuckey, J.; Krajewski, K.; Jiang, S.; Roller, P. P.; Wang, S. Structure-based design of flavonoid compoundsas a new class of small-molecule inhibitors of the anti-apoptotic bcl-2proteins. J. Med. Chem., 2007, 50, 3163-3166.
79. Lee, E. R.; Kang, Y. J.; Kim, J. H.; Lee, H. T.; Cho, S. G. Modulation ofapoptosis in HaCaT keratinocytes via differential regulation of ERK signalingpathway by flavonoids. J. Biol. Chem., 2005, 280, 31498-31507.
80. Jang, S.; Kelley, K. W.; Johnson, R. W. Luteolin reduces IL-6 production inmicroglia by inhibiting JNK phosphorylation and activation of AP-1. Proc.Natl. Acad. Sci. U. S. A., 2008, 105, 7534-7539.
81. Chen, C. Y.; Peng, W. H.; Tsai, K. D.; Hsu, S. L. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappa B and AP-1activation pathway in mouse alveolar macrophages. Life Sci., 2007, 81,1602-1614.
82. Zhu, M.; Rajamani, S.; Kaylor, J.; Han, S.; Zhou, F. M.; Fink, A. L. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregatesexisting fibrils. J. Biol. Chem., 2004, 279, 26846-26857.
83. Yue, G. G. L.; Yip, T. W. N.; Huang, Y.; Ko, W. H. Cellular mechanism forpotentiation of Ca2+-mediated Cl- secretion by the flavonoid baicalein in intestinalepithelia. J. Biol. Chem., 2004, 279, 39310-39316.
84. Lee, Y.; Yeo, H.; Liu, S. H.; Jiang, Z.; Savizky, R. M.; Austin, D. J.; Cheng,Y. c. Increased anti-P-glycoprotein activity of baicalein by alkylation on thea ring. J. Med. Chem., 2004, 47, 5555-5566.
85. Ko, C. H.; Shen, S. C.; Lee, T. J. F.; Chen, Y. C. Myricetin inhibits matrixmetalloproteinase 2 protein expression and enzyme activity in colorectal carcinomacells. Mol. Cancer Ther., 2005, 4, 281-290.
86. Hsu, Y. L.; Chang, J. K.; Tsai, C. H.; Chien, T. T. C.; Kuo, P. L. Myricetininduces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem. Pharmacol.,2007, 73, 504-514.
87. Shih, Y. W.; Wu, P. F.; Lee, Y. C.; Shi, M. D.; Chiang, T. A. Myricetinsuppresses invasion and migration of human lung adenocarcinoma A549cells: possible mediation by blocking the ERK signaling pathway. J. Agric.Food. Chem., 2009, 57, 3490-3499.
88. Schutte, M. E.; Sandt, J. J. M. V. D.; Alink, G. M.; Groten, J. P.; Rietjens, I.M. C. M. Myricetin stimulates the absorption of the pro-carcinogen PhIP. Cancer Letters, 2006, 231, 36-42.
89. Kumamoto, T.; Fujii, M.; Hou, D. X. Myricetin directly targets JAK1 toinhibit cell transformation. Cancer Lett., 2009, 275, 17-26.
90. Maloney, D. J.; Deng, J. Z.; Starck, S. R.; Gao, Z.; Hecht, S. M. (+)-Myristinin A, a naturally occurring DNA polymerase â Inhibitor and potentDNA-damaging agent. J. Am. Chem. Soc, 2005, 127, 4140-4141.
91. Welford, R. W. D.; Schlemminger, I.; McNeill, L. A.; Hewitson, K. S.; Schofield, C. J. The selectivity and inhibition of AlkB. J. Biol. Chem., 2003,278, 10157-10161.
92. Spencer, J. P. E.; Rice-Evans, C.; Williams, R. J. Modulation of pro-survivalAkt/protein kinase B and ERK1/2 signaling cascades by quercetin and its invivo metabolites underlie their action on neuronal viability. J. Biol. Chem.,2003, 278, 34783-34793.
93. Khan, N.; Afaq, F.; Syed, D. N.; Mukhtar, H. Fisetin, a novel dietary flavonoid,causes apoptosis and cell cycle arrest in human prostate cancer LNCaPcells. Carcinogenesis, 2008, 29, 1049-1056.
94. Maher, P.; Akaishi, T.; Abe, A. K. Flavonoid fisetin promotes ERKdependentlong-term potentiation and enhances memory. Proc. Natl. Acad.Sci. U. S. A., 2006, 103, 16568-16573.
95. Liao, Y. C.; Shih, Y. W.; Chao, C. H.; Lee, X. Y.; Chiang, T. A. Involvementof the ERK signaling pathway in fisetin reduces invasion and migration inthe human lung cancer cell line A549. J. Agric. Food. Chem., 2009, 57,8933-8941.
96. Borradaile, N. M.; Dreu, L. E. D.; Barrett, P. H. R.; Behrsin, C. D.; Huff, M.W. Hepatocyte apoB-containing lipoprotein secretion Is decreased by thegrapefruit flavonoid, naringenin, via Inhibition of MTP-mediated microsomaltriglyceride accumulation. Biochemistry, 2003, 42, 1283-1291.
97. Wu, J. B.; Fong, Y. C.; Tsai, H. Y.; Chen, Y. F.; Tsuzuki, M.; Tang, C. H. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur. J. Pharmacol., 2008, 588,333-341.
98. Zhou, C. H.; Wu, X. H.; Wu, Y. Q. Nobiletin, a dietary phytochemical,inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway. Eur. J. Pharmacol., 2009, 615, 55-60.
99. Manthey, J. A.; Guthrie, N.; Grohmann, K. K. Biological properties of citrusflavonoids pertaining to cancer and inflammation. Curr. Med. Chem., 2001,8, 135-153.
100. Larsen, C. A.; Bisson, W. H.; Dashwood, R. H. Tea catechins inhibit hepatocytegrowth factor receptor (MET kinase) activity in human colon cancercells: kinetic and molecular docking studies. J. Med. Chem., 2009, 52, 6543-6545.
101. Shim, J. H.; Choi, H. S.; Pugliese, A.; Lee, S. Y.; Chae, J. I.; Choi, B. Y.; Bode, A. M.; Dong, Z. (-)-Epigallocatechin gallate regulates CD3-mediatedT cell receptor signaling in leukemia through the inhibition of ZAP-70kinase. J. Biol. Chem., 2008, 283, 28370-28379.
102. Kundu, J. K.; Hwang, D. M.; Lee, J. C.; Chang, E. J.; Shin, Y. K.; Fujii, H.; Sun, B.; Surh, Y. J. Inhibitory effects of oligonol on phorbol ester-inducedtumor promotion and COX-2 expression in mouse skin: NF-kappa B andC/EBP as potential targets. Cancer Lett., 2009, 273, 86-97.
103. Ogborne, R. M.; Rushworth, S. A.; O'Connell, M. A. Epigallocatechin activateshaem oxygenase-1 expression via protein kinase C delta and Nrf2. Biochem.Biophys. Res. Commun., 2008, 373, 584-588.
104. Fukuhara, K.; Nakanishi, I.; Kansui, H.; Sugiyama, E.; Kimura, M.; Shimada, T.; Urano, S.; Yamaguchi, K.; Miyata, N. Enhanced radicalscavengingactivity of a planar catechin analogue. J. Am. Chem. Soc., 2002,124, 5952-5953.
105. Kang, N. J.; Lee, K. W.; Lee, D. E.; Rogozin, E. A.; Bode, A. M.; Lee, H. J.; Dong, Z. G. Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase. J. Biol. Chem., 2008, 283, 20664-20673.
106. Carter, D. C.; Ho, J. X. Structure of serum-albumin. Adv. Protein Chem.,1994, 45, 153-203.
107. Shao, J. Y.; Shen, H.; Havsteen, B. Purification, characterization and bindinginteractions of the Chinese-cobra (Naja naja atra) serum antitoxic proteinCSAP. Biochem. J, 1993, 293, 559-566.
108. Peters, T. All about Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press: San Diego, 1996.
109. Sasnouski, S.; Zorin, V.; Khludeyev, I.; D'Hallewin, M. A.; Guillemin, F.; Bezdetnaya, L. Investigation of foscan (R) interactions with plasma proteins. Biochim. Biophys. Acta, 2005, 1725, 394-402.
110. Vorum, H.; Honore, B. Influence of fatty acids on the binding of warfarinand phenprocoumon to human serum albumin with relation to anticoagulanttherapy. J. Pharm. Pharmacol., 1996, 48, 870-875.
111. He, X. M.; Carter, D. C. Atomic-structure and chemistry of human serumalbumin. Nature, 1992, 358, 209-215.
112. Kratochwil, N. A.; Huber, W.; Muller, F.; Kansy, M.; Gerber, P. R. Predictingplasma protein binding of drugs: a new approach. Biochem. Pharmacol.,2002, 64, 1355-1374.
113. Zsila, F.; Bikadi, Z.; Simonyi, M. Probing the binding of the flavonoid,quercetin to human serum albumin by circular dichroism, electronic absorptionspectroscopy and molecular modelling methods. Biochem. Pharmacol.,2003, 65, 447-456.
114. Dufour, C.; Dangles, O. Flavonoid-serum albumin complexation: determinationof binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta, 2005, 1721, 164-173.
115. Sengupta, B.; Sengupta, P. K. Binding of quercetin with human serum albumin:a critical spectroscopic study. Biopolymers, 2003, 72, 427-434.
116. Dockal, M.; Carter, D. C.; Ruker, F. Conformational transitions of the threerecombinant domains of human serum albumin depending on pH. J. Biol.Chem., 2000, 275, 3042-3050.
117. Muzammil, S.; Kumar, Y.; Tayyab, S. Anion-induced refolding of humanserum albumin under low pH conditions. Biochim. Biophys. Acta, 2000,1476, 139-148.
118. Wetlaufe, D. B. Nucleation, rapid folding, and globular intrachain regions inproteins. Proc. Natl. Acad. Sci. U. S. A., 1973, 70, 697-701.
119. Huang, L.; Yu, D. Q. The Application of Ultra-violet Spectroscopy in Organic Chemistry. Scientific Press, Inc.: Beijing, 1988.
120. Xie, M. X.; Long, M.; Liu, Y.; Qin, C.; Wang, Y. D. Characterization of theinteraction between human serum albumin and morin. Biochim. Biophys.Acta, 2006, 1760, 1184-1191.
121. Xie, M. X.; Xu, X. Y.; Wang, Y. D. Interaction between hesperetin andhuman serum albumin revealed by spectroscopic methods. Biochim. Biophys.Acta, 2005, 1724, 215-224.
122. Ni, Y. N.; Zhang, X.; Kokot, S. Spectrometric and voltammetric studies ofthe interaction between quercetin and bovine serum albumin using warfarinas site marker with the aid of chemometrics. Spectrochim. Acta, Part A,2009, 71, 1865-1872.
123. Tian, J. N.; Liu, J. Q.; He, W. Y.; Hu, Z. D.; Yao, X. J.; Chen, X. G. Probingthe binding of scutellarin to human serum albumin by circular dichroism,fluorescence spectroscopy, FTIR, and molecular modeling method. Biomacromolecules,2004, 5, 1956-1961.
124. Gelamo, E. L.; Silva, C. H. T. P.; Imasato, H.; Tabak, M. Interaction ofbovine and human serum albumins with ionic surfactants: spectroscopy andmodeling. Biochim. Biophys. Acta, 2002, 1594, 84-99.
125. Yan, Y. L.; Marriott, G. Analysis of protein interactions using fluorescencetechnologies. Curr. Opin. Chem. Biol., 2003, 7, 635-640.
126. Eftink, M. R.; Ghiron, C. A. Fluorescence quenching studies with proteins. Anal. Biochem., 1981, 114, 199-227.
127. Lakowicz, J. R. Principles of Fluorescence Spectroscopy. Kluwer Academic/Plenum: New York, 1999.
128. Papadopoulou, A.; Green, R. J.; Frazier, R. A. Interaction of flavonoids withbovine serum albumin: a fluorescence quenching study. J. Agric. Food.Chem., 2005, 53, 158-163.
129. Tommasini, S.; Calabro, M. L.; Donato, P.; Raneri, D.; Guglielmo, G.; Ficarra, P.; Ficarra, R. Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources. J. Pharm. Biomed. Anal., 2004, 35, 389-397.
130. Kang, J.; Liu, Y.; Xie, M. X.; Li, S.; Jiang, M.; Wang, Y. D. Interactions ofhuman serum albumin with chlorogenic acid and ferulic acid. Biochim. Biophys.Acta, 2004, 1674, 205-214.
131. Sklar, L. A.; Hudson, B. S.; Simoni, R. D. Conjugated polyene fatty acids asfluorescent probes: binding to bovine serum albumin. Biochemistry, 1977,16, 5100-5108.
132. Cui, F. L.; Fan, J.; Li, J. P.; Hu, Z. D. Interactions between 1-benzoyl-4-pchlorophenylthiosemicarbazide and serum albumin: investigation by fluorescencespectroscopy. Bioorg. Med. Chem., 2004, 12, 151-157.
133. Chittur, K. K. FTIR/ATR for protein adsorption to biomaterial surfaces. Biomaterials, 1998, 19, 357-369.
134. Giacomelli, C. E.; Bremer, M. G. E. G.; Norde, W. ATR-FTIR study of IgGadsorbed on different silica surfaces. J. Colloid Interface Sci., 1999, 220, 13-23.
135. Pelton, J. T.; McLean, L. R. Spectroscopic methods for analysis of proteinsecondary structure. Anal. Biochem., 2000, 277, 167-176.
136. Surewicz, W. K.; Mantsch, H. H.; Chapman, D. Determination of proteinsecondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochemistry, 1993, 32, 389-394.
137. Byler, D. M.; Susi, H. Examination of the secondary structure of proteins bydeconvolved FTIR spectra. Biopolymers, 1986, 25, 469-487.
138. Liu, Y.; Xie, M. X.; Kang, J.; Zheng, D. Studies on the interaction of totalsaponins of panax notoginseng and human serum albumin by Fourier transforminfrared spectroscopy. Spectrochim. Acta, Part A, 2003, 59, 2747-2758.
139. Arrondo, J. L. R.; Muga, A.; Castresana, J.; Goni, F. M. Quantitative studiesof the structure of proteins in solution by Fourier-transform infrared spectroscopy. Prog. Biophys. Mol. Biol., 1993, 59, 23-56.
140. Kennedy, D. F.; Crisma, M.; Toniolo, C.; Chapman, D. Studies of peptidesforming 3(10)- and alpha-helices and beta-bend ribbon structures in organicsolution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry, 1991, 30, 6541-6548.
141. Fabian, H.; Naumann, D.; Misselwitz, R.; Ristau, O.; Gerlach, D.; Welfle, H. Secondary structure of streptokinase in aqueous solution: a Fourier transforminfrared spectroscopic study. Biochemistry, 1992, 31, 6532-6538.
142. Chehin, R.; Iloro, I.; Marcos, M. J.; Villar, E.; Shnyrov, V. L.; Arrondo, J. L.R. Thermal and pH-induced conformational changes of a beta-sheet proteinmonitored by infrared spectroscopy. Biochemistry, 1999, 38, 1525-1530.
143. Krimm, S.; Bandekar, J. Vibrational spectroscopy and conformation ofpeptides, polypeptides, and proteins. Adv. Protein Chem., 1986, 38, 181-364.
144. Xie, M. X.; Liu, Y. Studies on amide III infrared bands for the secondarystructure determination of proteins. Chem. J. Chinese U., 2003, 24, 226-231.
145. Mikhonin, A. V.; Bykov, S. V.; Myshakina, N. S.; Asher, S. A. Peptidesecondary structure folding reaction coordinate: correlation between UV ramanamide III frequency, psi ramachandran angle, and hydrogen bonding. J. Phys. Chem. B, 2006, 110, 1928-1943.
146. Cai, S. W.; Singh, B. R. A distinct utility of the amide III infrared band forsecondary structure estimation of aqueous protein solutions using partialleast squares methods. Biochemistry, 2004, 43, 2541-2549.
147. Lu, Z. X.; Cui, T.; Shi, Q. L. Applications of Circular Dichroism (CD) andOptical Rotatory Dispersion (ORD) in Molecular Biology. Science Press:Beijing, 1987.
148. Borch, J.; Jorgensen, T. J. D.; Roepstorff, P. Mass spectrometric analysis ofprotein interactions. Curr. Opin. Chem. Biol., 2005, 9, 509-516.
149. Winston, R. L.; Fitzgerald, M. C. Mass spectrometry as a readout of proteinstructure and function. Mass Spectrom. Rev., 1997, 16, 165-179.
150. Daniel, J. M.; Friess, S. D.; Rajagopalan, S.; Wendt, S.; Zenobi, R. Quantitativedetermination of noncovalent binding interactions using soft ionizationmass spectrometry. Int. J. Mass spectrom., 2002, 216, 1-27.
151. Loo, J. A. Studying noncovalent protein complexes by electrospray ionizationmass spectrometry. Mass Spectrom. Rev., 1997, 16, 1-23.
152. Tjernberg, A.; Carno, S.; Oliv, F.; Benkestock, K.; Edlund, P. O.; Griffiths, W. J.; Hallen, D. Determination of dissociation constants for protein-ligandcomplexes by electrospray ionization mass spectrometry. Anal. Chem., 2004,76, 4325-4331.
153. Clark, S. M.; Konermann, L. Determination of ligand-protein dissociationconstants by electrospray mass spectrometry-based diffusion measurements. Anal. Chem., 2004, 76, 7077-7083.
154. Frycak, P.; Schug, K. A. Dynamic titration: determination of dissociationconstants for noncovalent complexes in multiplexed format using HPLCESI-MS. Anal. Chem., 2008, 80, 1385-1393.
155. Loo, J. A. Electrospray ionization mass spectrometry: a technology forstudying noncovalent macromolecular complexes. Int. J. Mass spectrom.,2000, 200, 175-186.
156. Shoemaker, G. K.; Kitova, E. N.; Palcic, M. M.; Klassen, J. S. Equivalencyof binding sites in protein-ligand complexes revealed by time-resolved tandemmass spectrometry. J. Am. Chem. Soc., 2007, 129, 8674-8675.
157. De Vriendt, K.; Sandra, K.; Desmet, T.; Nerinckx, W.; Van Beeumen, J.; Devreese, B. Evaluation of automated nano-electrospray mass spectrometryin the determination of non-covalent protein-ligand complexes. Rapid Commun.Mass Spectrom., 2004, 18, 3061-3067.
158. Zhang, S.; Van Pelt, C. K.; Wilson, D. B. Quantitative determination ofnoncovalent binding interactions using automated nanoelectrospray massspectrometry. Anal. Chem., 2003, 75, 3010-3018.
159. Pramanik, B. N.; Bartner, P. L.; Mirza, U. A.; Liu, Y. H.; Ganguly, A. K.Electrospray ionization mass spectrometry for the study of non-covalentcomplexes: an emerging technology. J. Mass Spectrom., 1998, 33, 911-920.
160. Roberts, G. C. K. NMR spectroscopy in structure-based drug design. Curr.Opin. Biotechnol., 1999, 10, 42-47.
161. Fielding, L. NMR methods for the determination of protein-ligand dissociationconstants. Curr. Top. Med. Chem., 2003, 3, 39-53.
162. Meyer, B.; Peters, T. NMR Spectroscopy techniques for screening and identifyingligand binding to protein receptors. Angew. Chem. Int. Ed., 2003, 42,864-890.
163. Salvatella, X.; Giralt, E. NMR-based methods and strategies for drug discovery. Chem. Soc. Rev., 2003, 32, 365-372.
164. Hajduk, P. J.; Mack, J. C.; Olejniczak, E. T.; Park, C.; Dandliker, P. J.; Beutel, B. A. SOS-NMR: a saturation transfer NMR-based method for determiningthe structures of protein-ligand complexes. J. Am. Chem. Soc.,2004, 126, 2390-2398.
165. Hamilton, J. A. Fatty acid interactions with proteins: what X-ray crystal andNMR solution structures tell us. Prog. Lipid Res., 2004, 43, 177-199.
166. Huang, H.; Melacini, G. High-resolution protein hydration NMR experiments:probing how protein surfaces interact with water and other noncovalentligands. Anal. Chim. Acta, 2006, 564, 1-9.
167. Zartler, E. R.; Shapiro, M. J. Protein NMR-based screening in drug discovery.Curr. Pharm. Des., 2006, 12, 3963-3972.
168. Fielding, L. NMR methods for the determination of protein-ligand dissociationconstants. Prog. Nucl. Magn. Reson. Spectrosc., 2007, 51, 219-242.
169. Shortridge, M. D.; Hage, D. S.; Harbison, G. S.; Powers, R. Estimatingprotein-ligand binding affinity using high-throughput screening by NMR. J. Comb. Chem., 2008, 10, 948-958.
170. Gounarides, J. S.; Chen, A. D.; Shapiro, M. J. Nuclear magnetic resonancechromatography: applications of pulse field gradient diffusion NMR to mixtureanalysis and ligand-receptor interactions. J. Chromatogr. B, 1999, 725,79-90.
171. Hicks, R. P. Recent advances in NMR: expanding its role in rational drugdesign. Curr. Med. Chem., 2001, 8, 627-650.
172. Clarkson, J.; Campbell, I. D. Studies of protein-ligand interactions by NMR.Biochem. Soc. Trans., 2003, 31, 1006-1009.
173. Post, C. B. Exchange-transferred NOE spectroscopy and bound ligand structuredetermination. Curr. Opin. Struct. Biol., 2003, 13, 581-588.
174. Constantine, K. L.; Davis, M. E.; Metzler, W. J.; Mueller, L.; Claus, B. L. Protein-ligand NOE matching: a high-throughput method for binding poseevaluation that does not require protein NMR resonance assignments. J. Am.Chem. Soc., 2006, 128, 7252-7263.
175. Carlomagno, T. Ligand-target interactions: what can we learn from NMR? Annu. Rev. Biophys. Biomol. Struct., 2005, 34, 245-266.
176. Zhong, W. Y.; Wang, Y. C.; Yu, J. S.; Liang, Y. Q.; Ni, K. Y.; Tu, S. Z. Theinteraction of human serum albumin with a novel antidiabetic agent - SU -118. J. Pharm. Sci., 2004, 93, 1039-1046.
177. Murota, K.; Terao, J. Antioxidative flavonoid quercetin: implication of itsintestinal absorption and metabolism. Arch. Biochem. Biophys., 2003, 417,12-17.
178. Boots, A. W.; Haenen, G.; Bast, A. Health effects of quercetin: from antioxidantto nutraceutical. Eur. J. Pharmacol., 2008, 585, 325-337.
179. Harwood, M.; Danielewska-Nikiel, B.; Borzelleca, J. F.; Flamm, G. W.; Williams, G. M.; Lines, T. C. A critical review of the data related to thesafety of quercetin and lack of evidence of in vivo toxicity, including lack ofgenotoxic/carcino genic properties. Food Chem. Toxicol., 2007, 45, 2179-2205.
180. Su, Z.; Qin, C.; Xie, M. X.; Li, J. D.; Wang, Y. D. Spectroscopic investigationof the binding of the active comonents of aocynum venetum L. to humanserum albumin. Acta Chim. Sinica, 2007, 65, 329-336.
181. Cao, H.; Wu, D. H.; Wang, H. X.; Xu, M. Effect of the glycosylation offlavonoids on interaction with protein. Spectrochim. Acta, Part A, 2009, 73,972-975.
182. Sengupta, B.; Sengupta, P. K. The interaction of quercetin with human serumalbumin: a fluorescence spectroscopic study. Biochem. Biophys. Res. Commun.,2002, 299, 400-403.
183. Gutzeit, H. O.; Henker, Y.; Kind, B.; Franz, A. Specific interactions ofquercetin and other flavonoids with target proteins are revealed by elicitedfluorescence. Biochem. Biophys. Res. Commun., 2004, 318, 490-495.
184. Bohl, M.; Czupalla, C.; Tokalov, S. V.; Hoflack, B.; Gutzeit, H. O. Identificationof actin as quercetin-binding protein: an approach to identify targetmolecules for specific ligands. Anal. Biochem., 2005, 346, 295-299.
185. Kanakis, C. D.; Tarantilis, P. A.; Polissiou, M. G.; Diamantoglou, S.; Tajmir-Riahi, H. A. Antioxidant flavonoids bind human serum albumin. J. Mol.Struct., 2006, 798, 69-74.
186. Cooray, H. C.; Janvilisri, T.; van Veen, H. W.; Hladky, S. B.; Barrand, M. A.Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun., 2004, 317, 269-275.
187. Lapidot, T. M.; Walker, M. D.; Kanner, J. Antioxidant and prooxidant effectsof phenolics on pancreatic beta-cells in vitro. J. Agric. Food. Chem., 2002,50, 7220-7225.
188. Guharay, J.; Sengupta, B.; Sengupta, P. K. Protein-flavonol interaction:fluorescence spectroscopic study. Proteins, 2001, 43, 75-81.
189. Sengupta, B.; Banerjee, A.; Sengupta, P. K. Interactions of the plant flavonoidfisetin with macromolecular targets: insights from fluorescence spectroscopicstudies. J. Photochem. Photobiol. B, 2005, 80, 79-86.
190. Su, Z.; Xie, M. X.; Li, J. D.; Wang, Y. D. Spectroscopic characterization ofbinding between human serum albumin and 3, 3', 4', 7-tetradroxyflavone. Spectrosc. Spect. Anal., 2008, 28, 125-129.
191. Liu, Y.; Qin, C.; Hou, F.; Xie, M. X. Interaction between baicalein andvarious isomers of human serum albumin. Acta Chim. Sinica, 2009, 67, 629-636.
192. Xie, M. X.; Xu, X. Y.; Wang, Y. D.; Liu, Y. Spectroscopic investigation ofthe interaction between 2,3-dihydro4 ',5,7-trihydroxyflavone and human serumalbumin. Acta Chim. Sinica, 2005, 63, 2055-2062.
193. He, W. Y.; Li, Y.; Xue, C. X.; Hu, Z. D.; Chen, X. G.; Sheng, F. L. Effect ofChinese medicine alpinetin on the structure of human serum albumin. Bioorg. Med. Chem., 2005, 13, 1837-1845.
194. Zhang, Y.; Li, Y.; Dong, L.; Li, J. Z.; He, W. Y.; Chen, X. G.; Hu, Z. D. Investigation of the interaction between naringin and human serum albumin. J. Mol. Struct., 2008, 875, 1-8.
195. Li, Y.; He, W. Y.; Dong, Y. M.; Sheng, F. L.; Hu, Z. D. Human serum albumininteraction with formononetin studied using fluorescence anisotropy,FT-IR spectroscopy, and molecular modeling methods. Bioorg. Med. Chem.,2006, 14, 1431-1436.
196. He, W. Y.; Li, Y.; Liu, J. Q.; Hu, Z. D.; Chen, X. G. Specific interaction ofchalcone-protein: cardamonin binding site II on the human serum albuminmolecule. Biopolymers, 2005, 79, 48-57.
197. Zhang, S. Z.; Yang, X. N.; Morris, M. E. Combined effects of multipleflavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res., 2004, 21, 1263-1273.
198. Zhang, S. Z.; Yang, X. N.; Morris, M. E. Flavonoids are inhibitors of breastcancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol.,2004, 65, 1208-1216.
199. Ludwig, N.; Rolf, G.; Berger, S. Flavonoid binding to a multi-drug-resistancetransporter protein: an STD-NMR study. Anal. Bioanal.Chem., 2004, 379,1045-1049.
200. Chen, X. L.; Liu, H. X.; Qu, L. B.; Yu, Y. Z.; Lu, H. S.; Zhao, Y. F. Directobservation of a series of non-covalent complexes formed by phosphorylatedflavonoid-protein interactions through electrospray ionization tandem massspectroscopy. Anal. Chim. Acta, 2004, 511, 175-182.
201. Huang, Y. S.; ZHang, G. Y. Biochemistry and Molecular Biology. Scientific Press, Inc.: Beijing, 2004.
202. Wadkins, R. M.; Vladu, B.; Tung, C. S. Actinomycin D binds to metastablehairpins in single-stranded DNA. Biochemistry, 1998, 37, 11915-11923.
203. Robinson, H.; Priebe, W.; Chaires, J. B.; Wang, A. H. J. Binding of twonovel bisdaunorubicins to DNA studied by NMR spectroscopy. Biochemistry,1997, 36, 8663-8670.
204. Watson, J. D.; Crick, F. H. C. Molecular structure of nucleic acids - a sturcturefor deoxyribose nucleic acid. Nature, 1953, 171, 737-738.
205. Rauf, S.; Gooding, J. J.; Akhtar, K.; Ghauri, M. A.; Rahman, M.; Anwar, M.A.; Khalid, A. M. Electrochemical approach of anticancer drugs - DNA interaction. J. Pharm. Biomed. Anal., 2005, 37, 205-217.
206. Lerman, L. S. Structural considerations in interaction of DNA and acridines. J. Mol. Biol., 1961, 3, 18-30.
207. Kang, J. W.; Zhuo, L.; Lu, X. Q.; Liu, H. D.; Zhang, M.; Wu, H. X. Electrochemicalinvestigation on interaction between DNA with quercetin and Eu-Qu(3) complex. J. Inorg. Biochem., 2004, 98, 79-86.
208. Kanakis, C. D.; Tarantilis, P. A.; Polissiou, M. G.; Tajmir-Riahi, H. A.Interaction of antioxidant flavonoids with tRNA: intercalation or externalbinding and comparison with flavonoid-DNA adducts. DNA Cell Biol., 2006,25, 116-123.
209. Bi, S. Y.; Qiao, C. Y.; Song, D. Q.; Tian, Y.; Gao, D. J.; Sun, Y.; Zhang, H.Q. Study of interactions of flavonoids with DNA using acridine orange as afluorescence probe. Sens. Actuators B, 2006, 119, 199-208.
210. Tan, J.; Wang, B. C.; Zhu, L. C. DNA binding and oxidative DNA damageinduced by a quercetin copper(II) complex: potential mechanism of its antitumorproperties. J. Biol. Inorg. Chem., 2009, 14, 727-739.
211. Marinic, M.; Piantanida, I.; Rusak, G.; Zinic, M. Interactions of quercetinand its lanthane complex with double stranded DNA/RNA and singlestranded RNA: spectrophotometric sensing of poly G. J. Inorg. Biochem.,2006, 100, 288-298.
212. Zhou, J. L.; Qian, Z. M.; Luo, Y. D.; Tang, D.; Chen, H.; Yi, L.; Li, P. Screening and mechanism study of components targeting DNA from the chineseherb lonicera japonica by liquid chromatography/mass spectrometry andfluorescence spectroscopy. Biomed. Chromatogr., 2008, 22, 1164-1172.
213. Bocian, W.; Kawecki, R.; Bednarek, E.; Sitkowski, J.; Ulkowska, A.; Kozerski, L. Interaction of flavonoid topoisomerase I and II inhibitors with DNAoligomers. New J. Chem., 2006, 30, 467-472.
214. Kang, J. W.; Li, Z. F.; Lu, X. Q. Electrochemical study on the behavior ofmorin and its interaction with DNA. J. Pharm. Biomed. Anal., 2006, 40,1166-1171.
215. Nafisi, S.; Shadaloi, A.; Feizbakhsh, A.; Tajmir-Riahi, H. A. RNA binding toantioxidant flavonoids. J. Photochem. Photobiol. B, 2009, 94, 1-7.
216. Song, Y. M.; Kang, J. W.; Wang, Z. H.; Lu, X. Q.; Gao, J. Z.; Wang, L. F. Study on the interactions between CuL2 and morin with DNA. J. Inorg. Biochem.,2002, 91, 470-474.
217. Temerk, Y. M.; Ibrahim, M. S.; Kotb, M. Voltammetric and spectroscopicstudies on binding of antitumor morin, morin-Cu complex and morin-betacyclodextrinwith DNA. Spectrochim. Acta, Part A, 2009, 71, 1830-1836.
218. Wang, Z. F.; Cui, M.; Song, F. R.; Lu, L.; Liu, Z. Q.; Liu, S. Y. Evaluationof flavonoids binding to DNA duplexes by electrospray ionization massspectrometry. J. Am. Soc. Mass. Spectrom., 2008, 19, 914-922.
219. Sun, Y. T.; Bi, S. Y.; Song, D. Q.; Qiao, C. Y.; Mu, D.; Zhang, H. Q. Studyon the interaction mechanism between DNA and the main active componentsin Scutellaria baicalensis Georgi. Sens. Actuators B, 2008, 129, 799-810.
220. Sun, Z. Y.; Ma, Z.; Zhang, W. J.; Wang, X. Y.; Fan, C. H.; Li, G. X. Electrochemicalinvestigations of baicalin and DNA-baicalin interactions. Anal.Bioanal.Chem., 2004, 379, 283-286.
221. Zeng, Y. B.; Yang, N.; Liu, W. S.; Tang, N. Synthesis, characterization andDNA-binding properties of La(III) complex of chrysin. J. Inorg. Biochem.,2003, 97, 258-264.
222. Mello, L. D.; Pereira, R. M. S.; Sawaya, A. C. H. F.; Eberlin, M. N.; Kubota, L. T. Electrochemical and spectroscopic characterization of the interactionbetween DNA and Cu(II)-naringin complex. J. Pharm. Biomed. Anal., 2007,45, 706-713.
223. Bresloff, J. L.; Crothers, D. M. Equilibrium studies of ethidium--polynucleotide interactions. Biochemistry, 1981, 20, 3547-3553.
224. Pastre, D.; Pietrement, O.; Zozime, A.; Le Cam, E. Study of theDNA/ethidium bromide interactions on mica surface by atomic force microscope:influence of the surface friction. Biopolymers, 2005, 77, 53-62.
225. Mahadevan, S.; Palaniandava, M. Spectroscopic and voltammetric studies ofcopper(II) complexes of bis(pyrid-2-yl)-di/trithia ligands bound to calf thymus DNA. Inorg. Chim. Acta, 1997, 254, 291-302.
226. Kanakis, C. D.; Tarantilis, P. A.; Polissiou, M. G.; Diamantoglou, S.; Tajmir-Riahi, H. A. DNA interaction with naturally occurring antioxidant flavonoidsquercetin, kaempferol, and delphinidin. J. Biomol. Struct. Dyn., 2005, 22,719-724.
227. Wan, C. H.; Cui, M.; Song, F. R.; Liu, Z. Q.; Liu, S. Y. A study of the noncovalentinteraction between flavonoids and DNA triplexes by electrosprayionization mass spectrometry. Int. J. Mass spectrom., 2009, 283, 48-55.
228. Sytnik, A.; Gormin, D.; Kasha, M. Interplay between excited-state intramolecularproton transfer and charge transfer in flavonols and their use asprotein-binding-site fluorescence probes. Proc. Natl. Acad. Sci. U. S. A.,1994, 91, 11968-11972.
229. Sytnik, A.; Litvinyuk, I. Energy transfer to a proton-transfer fluorescenceprobe: tryptophan to a flavonol in human serum albumin. Proc. Natl. Acad.Sci. U. S. A., 1996, 93, 12959-12963.
230. Guharay, J.; Sengupta, P. K. Excited-state proton-transfer and dual fluorescenceof robinetin in different environments. Spectrochim. Acta, Part A,1997, 53, 905-912.